Literature DB >> 33633229

Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.

Yudibeth Sixto-López1, José Correa-Basurto1, Martiniano Bello1, Bruno Landeros-Rivera2, Jose Antonio Garzón-Tiznado3, Sarita Montaño4.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged coronavirus responsible for coronavirus disease 2019 (COVID-19); it become a pandemic since March 2020. To date, there have been described three lineages of SARS-CoV-2 circulating worldwide, two of them are found among Mexican population, within these, we observed three mutations of spike (S) protein located at amino acids H49Y, D614G, and T573I. To understand if these mutations could affect the structural behavior of S protein of SARS-CoV-2, as well as the binding with S protein inhibitors (cepharanthine, nelfinavir, and hydroxychloroquine), molecular dynamic simulations and molecular docking were employed. It was found that these punctual mutations affect considerably the structural behavior of the S protein compared to wild type, which also affect the binding of its inhibitors into their respective binding site. Thus, further experimental studies are needed to explore if these affectations have an impact on drug-S protein binding and its possible clinical effect.

Entities:  

Year:  2021        PMID: 33633229      PMCID: PMC7907372          DOI: 10.1038/s41598-021-84053-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  56 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Revealing noncovalent interactions.

Authors:  Erin R Johnson; Shahar Keinan; Paula Mori-Sánchez; Julia Contreras-García; Aron J Cohen; Weitao Yang
Journal:  J Am Chem Soc       Date:  2010-05-12       Impact factor: 15.419

Review 3.  Receptor recognition mechanisms of coronaviruses: a decade of structural studies.

Authors:  Fang Li
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

4.  Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.

Authors:  Fang Li; Wenhui Li; Michael Farzan; Stephen C Harrison
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

5.  Hydrogen-hydrogen bonding: a stabilizing interaction in molecules and crystals.

Authors:  Chérif F Matta; Jesús Hernández-Trujillo; Ting-Hua Tang; Richard F W Bader
Journal:  Chemistry       Date:  2003-05-09       Impact factor: 5.236

6.  Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus.

Authors:  Li-En Hsieh; Chao-Nan Lin; Bi-Ling Su; Tong-Rong Jan; Chi-Min Chen; Ching-Ho Wang; Dah-Sheng Lin; Chung-Tien Lin; Ling-Ling Chueh
Journal:  Antiviral Res       Date:  2010-08-23       Impact factor: 5.970

7.  In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Xueting Yao; Fei Ye; Miao Zhang; Cheng Cui; Baoying Huang; Peihua Niu; Xu Liu; Li Zhao; Erdan Dong; Chunli Song; Siyan Zhan; Roujian Lu; Haiyan Li; Wenjie Tan; Dongyang Liu
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

8.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.

Authors:  Hua-Hao Fan; Li-Qin Wang; Wen-Li Liu; Xiao-Ping An; Zhen-Dong Liu; Xiao-Qi He; Li-Hua Song; Yi-Gang Tong
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

9.  Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis.

Authors:  Joseph Thomas Ortega; Maria Luisa Serrano; Flor Helene Pujol; Hector Rafael Rangel
Journal:  EXCLI J       Date:  2020-03-18       Impact factor: 4.068

10.  The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.

Authors:  Farhana Musarrat; Vladimir Chouljenko; Achyut Dahal; Rafiq Nabi; Tamara Chouljenko; Seetharama D Jois; Konstantin G Kousoulas
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 20.693

View more
  8 in total

Review 1.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

2.  Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2.

Authors:  Zhi-Bi Zhang; Yuan-Ling Xia; Jian-Xin Shen; Wen-Wen Du; Yun-Xin Fu; Shu-Qun Liu
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

3.  Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection.

Authors:  Jian Li; Guangrui Chen; Zhiyun Meng; Zhuona Wu; Hui Gan; Xiaoxia Zhu; Peng Han; Taoyun Liu; Fanjun Wang; Ruolan Gu; Guifang Dou
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

4.  Community-level SARS-CoV-2 sequence diversity revealed by wastewater sampling.

Authors:  Candice L Swift; Mirza Isanovic; Karlen E Correa Velez; R Sean Norman
Journal:  Sci Total Environ       Date:  2021-08-18       Impact factor: 7.963

5.  Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica.

Authors:  Jose Arturo Molina-Mora
Journal:  Gene Rep       Date:  2022-02-08

6.  Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q.

Authors:  Shahzaib Ahamad; Kanipakam Hema; Shahnawaz Ahmad; Vijay Kumar; Dinesh Gupta
Journal:  3 Biotech       Date:  2022-03-03       Impact factor: 2.406

7.  A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.

Authors:  Chiranjib Chakraborty; Manojit Bhattacharya; Ashish Ranjan Sharma; Kuldeep Dhama; Govindasamy Agoramoorthy
Journal:  Geroscience       Date:  2022-08-22       Impact factor: 7.581

8.  SARS-CoV-2 Infections in Vaccinated and Unvaccinated Populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022.

Authors:  Catherine E Arnold; Logan J Voegtly; Emily K Stefanov; Matthew R Lueder; Andrea E Luquette; Robin H Miller; Haven L Miner; Andrew J Bennett; Lindsay Glang; Tara N McGinnis; Kristie E Reisinger; Jae W Dugan; Michael A Mangat; Daniel J Silberger; Rebecca L Pavlicek; Chaselynn M Watters; Gregory K Rice; Francisco Malagon; Regina Z Cer; Stephen M Eggan; Kimberly A Bishop-Lilly
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.